EdgarLookup
SC 13D/A

AMENDMENT NO. 5 TO SCHEDULE 13D

Company
Altamira Therapeutics Ltd.
Filed
October 6, 2020
Accession Number
0001213900-20-030319
View Document ↗ View on SEC.gov ↗